*Safety information: Alpha Chews is a compounded oral medication combining tadalafil and vardenafil, along with vitamin D3 and K2, prescribed for use as directed by your provider. Common side effects can include headache, flushing, or upset stomach. Alpha Chews should not be combined with nitrates or certain heart medications. Discontinue use and consult your provider if you experience any concerning symptoms.
Compounded medications are not FDA-approved. They are prepared by licensed U.S. pharmacies based on a prescription from a licensed healthcare provider when deemed medically appropriate. Compounded medications are not evaluated by the FDA for safety, efficacy, or quality.
This treatment is provided only after a licensed provider determines it's appropriate for you, and individual results may vary.
Medical treatment is provided following review by a licensed healthcare professional. Product formulation, packaging, and appearance may vary.
Cialis® and Levitra® are registered trademarks of their respective owners and are not affiliated with or endorsed by Society.

References:
*Porst, H., Padma-Nathan, H., Giuliano, F., Anglin, G., Varanese, L., & Rosen, R. (2003). Efficacy of tadalafil for the treatment of erectile dysfunction at 24 and 36 hours after dosing: a randomized controlled trial. Urology, 62(1), 121-125.
*Montorsi, F., Padma-Nathan, H., Buvat, J., Schwaibold, H., Beneke, M., Ulbrich, E., Bandel, T.J., & Porst, H. (2004). Earliest time to onset of action leading to successful intercourse with vardenafil determined in an at-home setting: a randomized, double-blind, placebo-controlled trial. The Journal of Sexual Medicine, 1(2), 168-178.
*Hellstrom, W.J.G., Gittelman, M., Karlin, G., Segerson, T., Thibonnier, M., Taylor, T., & Padma-Nathan, H. (2002). Vardenafil for treatment of men with erectile dysfunction: efficacy and safety in a randomized, double-blind, placebo-controlled trial. Journal of Andrology, 23(6), 763-771.
*Arian, I., Dumbraveanu, I., Creciun, M., Karabacak, O.Y., Bogdanov, A., Dumbraveanu, I.I., Balan, S., & Ceban, E. (2026). Combined use of tadalafil and vardenafil in men with erectile dysfunction non-responsive to monotherapy with a single PDE5 inhibitor: clinical rationale and preliminary outcomes. The Journal of Sexual Medicine, 23(Supplement_4), qdag118.681.